Advanced search

An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen.

Geert VERGOTE (UGent) , Chris Vervaet (UGent) , Isabel Van Driessche (UGent) , Serge Hoste (UGent) , Stefaan De Smedt (UGent) , Jo Demeester (UGent) , RA JAIN, S RUDDY and Jean Paul Remon (UGent)
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
VERGOTE, Geert, Chris Vervaet, Isabel Van Driessche, Serge Hoste, Stefaan De Smedt, Jo Demeester, RA JAIN, S RUDDY, and Jean Paul Remon. 2001. “An Oral Controlled Release Matrix Pellet Formulation Containing Nanocrystalline Ketoprofen.” International Journal of Pharmaceutics 219 (1-2): 81–87.
APA
VERGOTE, Geert, Vervaet, C., Van Driessche, I., Hoste, S., De Smedt, S., Demeester, J., JAIN, R., et al. (2001). An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 219(1-2), 81–87.
Vancouver
1.
VERGOTE G, Vervaet C, Van Driessche I, Hoste S, De Smedt S, Demeester J, et al. An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen. INTERNATIONAL JOURNAL OF PHARMACEUTICS. 2001;219(1-2):81–7.
MLA
VERGOTE, Geert, Chris Vervaet, Isabel Van Driessche, et al. “An Oral Controlled Release Matrix Pellet Formulation Containing Nanocrystalline Ketoprofen.” INTERNATIONAL JOURNAL OF PHARMACEUTICS 219.1-2 (2001): 81–87. Print.
@article{148593,
  author       = {VERGOTE, Geert and Vervaet, Chris and Van Driessche, Isabel and Hoste, Serge and De Smedt, Stefaan and Demeester, Jo and JAIN, RA and RUDDY, S and Remon, Jean Paul},
  issn         = {0378-5173},
  journal      = {INTERNATIONAL JOURNAL OF PHARMACEUTICS},
  language     = {eng},
  number       = {1-2},
  pages        = {81--87},
  title        = {An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen.},
  volume       = {219},
  year         = {2001},
}

Web of Science
Times cited: